Uncertainty-Aware Multiscale Treatment Response Forecasting in Advanced Non-Small Cell Lung Cancer Using Residual-Variance Conformal Prediction

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Voxel-level prediction of treatment response from longitudinal Fluorodexoyglucose (FDG) positron emission tomography / computed tomography (PET/CT) can enable spatially adaptive dose planning in advanced non-small cell lung cancer (NSCLC), but point predictions alone lack the uncertainty quantification needed for safe clinical decision-making. Standard conformal prediction (CP) provides distribution-free coverage but yields spatially uniform intervals and assumes exchangeability—an assumption violated by intra-tumoral spatial correlation. We propose a multiscale CP framework built on a re-optimized VoxelForecast generalized least squares model that explicitly captures voxel-level covariance. Variogram sensitivity analysis identified the Stable model as significantly superior to previouly used Matérn family. The framework combines hierarchical nested leave-one-patient-out calibration, which restores exchangeability for valid voxel-level coverage, with residual-variance CP (VarCP), which learns a heteroscedastic, location-dependent scale to produce adaptive intervals while preserving finite-sample marginal coverage guarantees. On two prospective NSCLC trial cohorts—FLARE-RT (N=25 locally advanced, chemoradio-therapy; 11,100 voxels) and BRIGHT (N=19 metastatic, chemoimmunotherapy; 26,980 voxels)—multiscale feature integration reduced voxel-level prediction error by 35% and 31%, respectively. VarCP maintained nominal coverage while producing 7–18% (FLARE-RT) and 4–8% (BRIGHT) narrower voxel-level intervals than a hierarchically calibrated standard CP baseline (paired Wilcoxon signed-rank, significant at most miscoverage levels), with comparable lesion-level gains (7–18% and 6–10%) via median-based aggregation of voxel residuals. VarCP delivers tighter yet mathematically guaranteed spatial uncertainty maps, supporting both voxel-level dose-adjustment and whole-lesion treatment planning in advanced NSCLC.

Article activity feed